Ajinomoto Co., Inc. (AJINY)

OTCMKTS · Delayed Price · Currency is USD
28.30
+0.32 (1.14%)
Feb 11, 2026, 3:41 PM EST
Market Cap26.83B +34.2%
Revenue (ttm)9.85B +1.4%
Net Income494.81M -15.6%
EPS0.50 -12.7%
Shares Outn/a
PE Ratio54.22
Forward PEn/a
Dividend0.31 (1.18%)
Ex-Dividend DateMar 30, 2026
Volume1,100
Average Volume66,860
Open28.06
Previous Close27.98
Day's Range28.06 - 28.30
52-Week Range16.50 - 30.49
Beta0.09
RSI80.37
Earnings DateFeb 5, 2026

About Ajinomoto Co.

Ajinomoto Co., Inc. engages in the seasonings and foods, frozen foods, and healthcare and other businesses in Japan and internationally. The Seasonings and Foods segment offers sauces and seasoning products under the AJI-NO-MOTO, HON-DASHI, Cook Do, Ajinomoto KK Consommé, Pure Select Mayonnaise, Ros Dee, Masako, Aji-ngon, Sazón, Sajiku, and CRISPY FRY names. This segment also provides instant noodles under the Knorr Cup Soup and YumYum names; coffee beverages under the Birdy and Blendy brands; powdered drink under the Birdy 3in1 name; MAXIM bra... [Read more]

Founded 1909
Employees 34,860
Stock Exchange OTCMKTS
Ticker Symbol AJINY
Full Company Profile

Financial Performance

In fiscal year 2025, Ajinomoto Co.'s revenue was 1.53 trillion, an increase of 6.35% compared to the previous year's 1.44 trillion. Earnings were 70.27 billion, a decrease of -19.34%.

Financial numbers in JPY Financial Statements

News

Q3 2026 Ajinomoto Co Inc Earnings Presentation Transcript

Q3 2026 Ajinomoto Co Inc Earnings Presentation Transcript

5 days ago - GuruFocus

Ajinomoto Co GAAP EPS of ¥91.82, revenue of ¥1.16B

Ajinomoto Co press release (AJINY): 9M GAAP EPS of ¥91.82. Revenue of ¥1.16B.

6 days ago - Seeking Alpha

Q2 2026 Ajinomoto Co Inc Earnings Presentation Transcript

Q2 2026 Ajinomoto Co Inc Earnings Presentation Transcript

3 months ago - GuruFocus

Ajinomoto Co reports 1H results

Get the latest on Ajinomoto Co’s 1H results: ¥52.18 EPS and ¥738.88B sales.

3 months ago - Seeking Alpha

Full Year 2025 Ajinomoto Co Inc Earnings Presentation Transcript

Full Year 2025 Ajinomoto Co Inc Earnings Presentation Transcript

3 months ago - GuruFocus

A winning formula

To elevate athletic performance, the Sports Authority of Thailand (SAT)has collaborated with Ajinomoto to launch the Ajinomoto Victory Canteen at SAT as the nation's main sports nutrition centre. Acco...

3 months ago - Bangkok Post

Ajinomoto Co., Inc. - Special Call

4 months ago - Seeking Alpha

Ajinomoto Co., Inc. (AJINY) Q4 2025 Earnings Call Transcript

Ajinomoto Co., Inc. (OTCPK:AJINY) Q4 2025 Results Conference Call May 8, 2025 5:00 AM ETCompany ParticipantsMasataka Kaji - Investor Relations...

9 months ago - Seeking Alpha

Ajinomoto Co GAAP EPS of ¥69.77

9 months ago - Seeking Alpha

Part of $1 Billion Investment Strategy, PCI Pharma Services Completes Acquisition of Ajinomoto Althea, Enhancing US Drug Product Manufacturing for Aseptic Filling of Prefilled Syringes & Cartridges

PHILADELPHIA--(BUSINESS WIRE)--PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – has completed its a...

10 months ago - Business Wire

L-Phenylalanine Market Insights and Forecast to 2030 Featuring Profiles (SWOT, Sales, Prices) of Key Players - Evonik, Ajinomoto, Daesang, and Wuxi Jinghai Amino Acid Co.

Dublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "L-Phenylalanine Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application" report has been added to...

10 months ago - GlobeNewsWire

L-Alanyl-L-Glutamine Market Report 2025: Includes Insights Into the Sales, Revenue, Price, Gross Margin & SWOT of Kyowa Hakko, Ajinomoto, and Evonik

Dublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "L-Alanyl-L-Glutamine Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application" report has been add...

10 months ago - GlobeNewsWire

PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea

PHILADELPHIA--(BUSINESS WIRE)--PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – is acquiring an ent...

10 months ago - Business Wire

Q3 2025 Ajinomoto Co Inc Earnings Presentation Transcript

Q3 2025 Ajinomoto Co Inc Earnings Presentation Transcript

1 year ago - GuruFocus

Q2 2025 Ajinomoto Co Inc Earnings Presentation Transcript

Q2 2025 Ajinomoto Co Inc Earnings Presentation Transcript

1 year ago - GuruFocus

Ajinomoto Co., Inc. 2024 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Ajinomoto Co., Inc.

1 year ago - Seeking Alpha